Suppression of proinflammatory cytokine production by specific metabolites of Lactobacillus plantarum 10hk2 via inhibiting NF-κB and p38 MAPK expressions

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2010, Pages

  Chon, Heeson ^a   Choi, Byungryul ^a   Jeong, Gajin ^b   Lee, Eungyo ^c   Lee, Seunghui ^c  

^a Milae Resources ML Co Ltd   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anti inflammation; IL 10; Lactic acid bacteria; NF B; P38 MAPK; RAW 264.7 cells

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; LACTOBACILLUS PLANTARUM; LACTOBACILLUS PLANTARUM 10HK2; MACROPHAGE; METABOLITE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; ELECTROPHORESIS, CAPILLARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; IMMUNOMODULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LACTOBACILLUS PLANTARUM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PHOSPHORYLATION; POLYSACCHARIDES, BACTERIAL; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS PLANTARUM; MURINAE;

EID: 78650219775     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2009.11.002     Document Type: Article

References (39)

1. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993, 81:2844-2853.
2. Valledor A.F., Borras F.E., Cullell-Young M., Celada A. Transcription factor that regulate monocytes/macrophage differentiation. J Leuk Biol 1998, 63:405-417.
3. Beutler B., Krochin N., Milsark I.W., Luedke C., Cerami A. Control of cachechin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986, 232:977-980.
4. Ezoulin M.J.M., Liu Z., Dutertre-Catella H., Wu G., Dong C.Z., Heymans F., et al. A new acetylcholineseterase inhibitor with anti-PAF activity modulated oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine. Int Immunopharmacol 2007, 7:1685-1694.
5. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
6. Shin E.M., Zhou H.Y., Guo L.Y., Kim J.A., Lee S.H., Merfort I., et al. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol 2008, 8:1524-1532.
7. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20.
8. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
9. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994, 12:141-179.
10. Ghosh S., May M.J., Kopp E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
11. Mendis E., Kim M., Rajapakse N., Kim S. Suppression of cytokine production in lipopolysaccharides-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-κB and MAPK expressions. Bioorg Med Chem 2008, 16:8390-8396.
12. Lopez-Neblina F., Toledo-Pereyra L.H. Phosphoregulation of signal transduction pathways in ischemia and reperfusion. J Surg Res 2006, 134:292-299.
13. Sironi L., Banfi C., BAc rioschi M., Gelosa P., Guerrini U., Nobili E., et al. Activation of NF-κB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol Dis 2006, 22:445-451.
14. Bolger A.P., Sharma R., von Haehling S., Doehner W., Oliver B., Rauchhaus M., et al. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol 2002, 90:384-389.
15. Waal-Malefyt R., Abrams J., Bennett B., Figdor C.G., Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes. J Exp Med 1991, 174:1209-1220.
16. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
17. Mosmann T.R. Properties and functions of interleukin-10. Adv Immunol 1994, 56:1-26.
18. Lentsch A.B., Shanley T.P., Sarma V., Ward P.A. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997, 100:2443-2448.
19. Li Q., Verma I.M. NF-kappa B regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
20. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270:9558-9563.
21. Chon H., Choi B., Lee E., Lee S., Jeong G. Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264.7. J Appl Microbiol 2009, 107:1588-1597.
22. Ménard S., Candalh C., Bambou J.C., Terpend K., Cerf-Bensussan N., Heyman H. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004, 53:821-828.
23. Landersjö C., Yang Z., Huttunen E., Wildmalm G. Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). Biomacromolecules 2002, 3:880-884.
24. Park S.Y., Pestka J.J., Ji G.E., Ko Y.T., Jung H.K., Ustunol Z. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolated of Bifidobacterium. Int J Food Microbiol 1999, 46:231-241.
25. Kim J.B., Han A.R., Park E.Y., Kim J.Y., Cho W.C., Lee J., et al. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NK-κB inactivation in RAW 264.7 macrophage cells. Biol Pharm Bull 2007, 30:2345-2351.
26. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., et al. Cytokine production by the murine macrophage cell line J774.1 after exposure to Lactobacilli. Biosci Biotechnol Biochem 2002, 66:1963-1966.
27. Waseem T., Duxbury M., Ito H., Ashley S.W., Robinson M.K. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008, 143:334-342.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
29. Bousse L., Mouradian S., Minalla A., Yee H., Williams K., Dubrow R. Protein sizing on a microchip. Anal Chem 2001, 73:1207-1212.
30. 4 samples. Electrophoresis 2004, 25:3890-3896.
31. Fareed D., Iqbal O., Tobu M., Hoppensteadt D.A., Fareed J. Blood levels of nitric oxide, C-creative protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implications. Clin Appl Thromb Hemost 2004, 10:357-364.
32. Kano H., Kaneko T., Kaminogawa S. Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice. J Food Prot 2002, 65:153-160.
33. Park J.Y., Kawada T., Han I.S., Kim B.S., Goto T., Takahashi N., et al. Capsaicin inhibits the production of tumor necrosis factor α by LPS-stimulated murine macrophages, RAW 264. 7: a PPARγ ligand-like action as a novel mechanism. Fed Eur Bio Society Lett 2004, 572:266-270.
34. Lammers K.M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003, 38:165-172.
35. He F., Morita H., Ouwehand A.C., Hosoda M., Hiramatsu M., Kurisaki J., et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002, 46:781-785.
36. Péna J.A., Versalovic J. Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 2003, 5:277-285.
37. Zhang X., Tao J., Zhao L., Huang Z., Xiong F., Zhang S., et al. In vitro anti-inflammatory effects of different solution fractions of ethanol extract from Melilotus suaveolens Ledeb. Chin Med J 2007, 120:1992-1998.
38. Lee H.S., Han S.Y., Bae E.A., Huh C.S., Ahn Y.T., Lee J.H., et al. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice. Int Immunopharmacol 2008, 8:574-580.
39. Jeon Y.J., Han S.B., Lee S.H., Kim H.C., Ahn K.S., Kim H.M. Activation of mitogen-activated protein kinase pathways by angelan in murine macrophages. Int Immunopharmacol 2001, 1:237-245.